E
Pangea Wellness Inc. PNGAF
$0.29 $0.027.41% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Pangea Wellness Inc. (PNGAF) is a publicly traded wellness-focused holding company quoted on the OTC Markets. The company has positioned itself within the health and wellness, consumer packaged goods, and functional food and supplement space, with an emphasis on products marketed as natural or plant-based. Based on publicly available disclosures, Pangea Wellness’ business model has centered on the development, branding, and distribution of wellness-oriented consumer products rather than large-scale manufacturing.

The company’s historical evolution reflects a series of strategic pivots common among small-cap OTC issuers. Pangea Wellness Inc. has undergone prior name and business focus changes, transitioning toward wellness-related consumer offerings in response to shifting market demand. Public information indicates that the company remains in an early or transitional stage of operations, with limited and inconsistent revenue generation reported historically. Data inconclusive based on available public sources regarding sustained profitability or large-scale commercial traction.

Business Operations

Pangea Wellness Inc.’s operations have primarily involved the identification and commercialization of wellness and lifestyle products, including functional foods, supplements, and related consumer health offerings. Revenue generation, where reported, has been derived from product sales and licensing or distribution arrangements rather than vertically integrated production. The company does not appear to operate large manufacturing facilities and has historically relied on third-party suppliers and co-packers.

Public disclosures do not clearly delineate formally reported operating segments, and the company has not consistently provided segment-level financial reporting comparable to SEC registrants. Domestic operations have been concentrated in North America, with limited evidence of sustained international sales. No material long-term joint ventures or large operating subsidiaries have been conclusively verified based on available public filings and OTC disclosures.

Strategic Position & Investments

Strategically, Pangea Wellness Inc. has communicated an intent to align with long-term consumer trends favoring natural wellness, preventative health, and lifestyle-oriented nutrition. Growth initiatives discussed historically have included brand development, potential acquisitions of small wellness brands, and expansion of distribution channels, particularly e-commerce. However, execution timelines and outcomes for these initiatives are not consistently documented.

The company has announced or explored various investments and acquisitions over time, but many have been early-stage, limited in scale, or not fully consummated. Data inconclusive based on available public sources regarding the current status, financial contribution, or materiality of specific portfolio investments or subsidiaries. No confirmed exposure to proprietary emerging technologies has been substantiated through independently verifiable filings.

Geographic Footprint

Pangea Wellness Inc. is headquartered in North America, with corporate activities primarily based in the United States. Its operational footprint appears modest, with most commercial efforts focused on domestic markets. International reach, where mentioned, has largely been aspirational or exploratory rather than supported by documented operating infrastructure.

There is no independently verified evidence of significant physical assets, manufacturing facilities, or long-term operational investments outside the United States. Any international market presence appears to be limited to distribution discussions or small-scale sales efforts rather than established foreign subsidiaries or regional headquarters.

Leadership & Governance

Pangea Wellness Inc.’s leadership structure reflects that of a small-cap OTC issuer, with a lean executive team overseeing corporate strategy, capital markets activity, and operational development. Governance practices are aligned with OTC Markets requirements rather than full SEC reporting standards, and the company has historically experienced executive and board turnover.

Key executives identified in public disclosures include:

  • Adam BoehlerChief Executive Officer
  • Patrick JohnsonChief Financial Officer
  • Brian SmithDirector

The leadership philosophy communicated by management has emphasized adaptability, opportunistic growth, and alignment with consumer wellness trends. However, detailed long-term strategic roadmaps and governance disclosures comparable to larger public companies remain limited.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $180.25
B
AAPL NASDAQ $250.12
B
MSFT NASDAQ $395.55
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $126.52
B
Top Financial Stocks
See All »
B
B
JPM NYSE $283.44
B
V NYSE $307.14
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $54.08
Top Health Care Stocks
See All »
B
LLY NYSE $985.08
B
JNJ NYSE $241.52
B
AMGN NASDAQ $366.21
Top Real Estate Stocks
See All »
B
PLD NYSE $131.75